Cocrystal Pharma (COCP)

• Market cap: $13M
• 1 day: -1.8%
• 5 days: -6.76%
• 1 month: -23.44%
• 3 months: -38.85%
• 6 months: -33.68%
• Year to date: -59.41%
• 1 year: -56.6%
• 5 years: -95.41%
• 10 years: -98.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Employees: 11